CRESY trades 8.7% below Wall Street's consensus target of $12.68.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CRESY achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) has a Wall Street consensus price target of $12.68, based on estimates from 1 covering analysts. With the stock currently trading at $11.66, this represents a potential upside of +8.7%. The company has a market capitalization of $747M.
Analyst price targets range from a low of $12.68 to a high of $12.68, representing a 0% spread in expectations. The median target of $12.68 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CRESY trades at a trailing P/E of 9999.0x.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $141345.66, with bear and bull scenarios of $89047.77 and $186237.04 respectively. Model confidence stands at 41/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
AGROAdecoagro S.A. | $5.2B | $9.24 | $9.00 | -2.6% | Hold | 5.2x | 8 |
BIOXBioceres Crop Solutions Corp. | $24M | $0.37 | — | — | — | — | — |
VNETVNET Group, Inc. | $2.4B | $8.75 | $19.03 | +117.5% | Buy | — | 16 |
LNDBrasilAgro - Companhia Brasileira de Propriedades Agrícolas | $356M | $3.57 | — | — | — | — | — |
FPIFarmland Partners Inc. | $426M | $9.76 | $17.00 | +74.2% | Hold | 52.8x | 15 |
LANDGladstone Land Corporation | $374M | $8.66 | $13.33 | +53.9% | Buy | — | 11 |
ALCOAlico, Inc. | $299M | $40.34 | $45.00 | +11.6% | Buy | — | 3 |
VITLVital Farms, Inc. | $446M | $10.41 | $12.86 | +23.5% | Buy | — | 16 |
ADMArcher-Daniels-Midland Company | $36.2B | $75.10 | $75.25 | +0.2% | Hold | 16.2x | 36 |
BGBunge Global S.A. | $21.8B | $112.58 | $133.67 | +18.7% | Buy | 12.1x | 25 |
Quick answers to the most common questions about buying CRESY stock.
The consensus price target for CRESY is $12.68, close to the current price of $11.66 (8.7% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.
CRESY has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $12.68 implies 8.7% upside from current levels.
CRESY's current price is $11.66 with a consensus target of $12.68 (8.7% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $12.6829 for CRESY, while the most conservative target is $12.6829. The consensus of $12.68 represents the median expectation. Our quantitative valuation model projects a bull case target of $186237 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CRESY is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CRESY stock forecast based on 1 Wall Street analysts shows a consensus price target of $12.68, with estimates ranging from $12.6829 (bear case) to $12.6829 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $141346, with bear/bull scenarios of $89048/$186237.
Our quantitative valuation model calculates CRESY's fair value at $141346 (base case), with a bear case of $89048 and bull case of $186237. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 41/100.
CRESY appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $12.68 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CRESY analyst price targets range from $12.6829 to $12.6829, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $12.68 consensus represents the middle ground. Our model's $89048-$186237 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.